System Medical Director Advanced Heart Failure

Fenningham, Dempster & Coval LLP; United States; Remote; USD 250,000 - 350,000; Full time

Job summary

Fenningham, Dempster & Coval LLP is seeking a System Medical Director for Advanced Heart Failure at Main Line Health's Lankenau Heart Group. This leadership role involves developing and overseeing heart failure care, requires a seasoned cardiologist with leadership skills, and offers a competitive compensation package along with excellent benefits.

Benefits

High income potential with competitive base compensation

Excellent benefits package

Financial security with a top-ranked hospital system

Qualifications

• Significant clinical experience managing advanced heart failure patients.
• Proven track record of leadership in academic or clinical settings.
• Active medical license in Pennsylvania.

Responsibilities

• Oversight of heart failure care delivery across hospitals.
• Program development and management.
• Community engagement and outreach.

Skills

Leadership

Patient-centered care

Multidisciplinary collaboration

Education

Medical degree (MD or DO)

Board certification in Cardiology and Advanced Heart Failure

Job description

System Medical Director Advanced Heart Failure

Main Line Health’s Lankenau Heart Group located in the near western suburbs of Philadelphia has a cardiology leadership opportunity for a System Medical Director of Advanced Heart Failure. We invite the qualified candidate to join our expanding, top-ranked cardiovascular program.

The System Medical Director of Advanced Heart Failure will be responsible for the development, implementation, and oversight of advanced heart failure care delivery across Main Line Hospitals and other Main Line Health affiliated facilities. This role requires a seasoned cardiologist with extensive experience in managing complex heart failure cases, including ECMO and VAD, along with demonstrated leadership skills to drive clinical excellence, research, and program growth.

Summary of Job Responsibilities:

• Clinical Leadership
• Program Development and Management
• Research and Education
• Quality Improvement and Compliance
• Community Engagement and Outreach
  

Qualifications:

• Medical degree (MD or DO) from an accredited institution, with board certification in Cardiology and Advanced Heart Failure and Transplant Cardiology subspecialties.
• Active medical license in the Commonwealth of PA, with eligibility for medical staff privileges at Main Line Hospitals.
• Significant clinical experience in managing advanced heart failure patients, including mechanical circulatory support and heart transplant evaluation.
• Proven track record of leadership in academic or clinical settings, with experience in program development, quality improvement, and research.
• Excellent interpersonal skills with the ability to collaborate effectively with multidisciplinary teams and engage with diverse stakeholders.
• Strong commitment to patient-centered care, clinical excellence, and continuous professional development.
  

Benefits and Lifestyle:

• High income potential with competitive base compensation and production incentives
• Excellent benefits package
• Financial security with working for a top ranked, financially secure hospital system
• Top ranked (nationally) public and private schools
• Less than 30 minute drive to historic Philadelphia
• Wonderful cultural opportunities
• Short drive to beaches, mountains, New York City and Washington, DC
  
  
  

Main Line Health is a 4-hospital system: Lankenau Medical Center, offering tertiary and quaternary care, is a comprehensive medical complex located on 93 acres just outside the western city limits of Philadelphia, with Bryn Mawr Hospital and Paoli Hospital to the west and Riddle Hospital to the South

Diversity is a core value at Main Line Health. We are committed to creating a diverse environment and are proud to be an equal opportunity employer.

More about Lankenau Heart Group: Building Hope with Ground-breaking Care

• The team of cardiologists and cardiovascular surgeons in one of the top-performing cardiovascular programs and among the region’s most trusted for cardiac care
• Nationally recognized clinical and basic research conducted through the Lankenau Institute for Medical Research (LIMR) providing access to the latest cardiovascular clinical trials, including novel medical devices, minimally invasive procedures, and medical therapies, many of which are not offered at other hospitals. Participation in multiple Early Feasibility Studies program, giving our patients opportunities for care only available at a handful of advanced institutions in the world
• A robust graduate medical education program with 18 general Fellows, in addition to structural, EP and Interventional Fellowships
• Nationally recognized clinician experts who specialize in minimally invasive treatment options:
  • More experience in minimally invasive robotic CABG/hybrid procedures than any hospital in the country—more than 2,200 procedures performed
  • At the forefront of advancing TAVR for patients with severe aortic stenosis as well as aortic regurgitation
  • Advanced investigational transcatheter-based novel technologies to treat aortic, mitral and tricuspid valve disease, in addition to multiple HF trials, both pharmaceutical and device-based.
  • One of only a few programs in the country performing complex aortic surgery
  • Peripheral intervention and endovascular options to treat vascular conditions, including PAD, DVT, carotid and venous disease with an active PERT program
    
    

• The latest in preventive cardiology including cardiovascular genetics
• An active Women’s Heart Initiative including cardio-obstetrics programs at multiple hospital locations
• Busy and growing advanced imaging programs including cardiac MR, PET-CT and Heartflow CCTA scans